Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | Cost Effectiveness and Resource Allocation

Fig. 4

From: Comparing swab- and different symptoms-based strategies to ascertain COVID-19 recovery in healthcare workers: a cost-effectiveness analysis

Fig. 4

Cost-effectiveness Acceptability Curve of the four competing strategies: SW: swab-based strategy; SY10-17: symptoms-based strategy with swabs scheduled at 10 and 17 days; SY14-17: symptoms-based strategy with swabs scheduled at 14 and 17 days; SY17: symptoms-based strategy with one swab at 17 days. Willingness to pay (WTP) was set at 160€ with interval of 10€ and is expressed as €/WDS: working days saved

Back to article page